SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Michigan Recalls Cannabis Edibles Over Potency Concerns

    By

    The Michigan Cannabis Regulatory Agency has recalled a number of cannabis edible products over potency concerns in Adrian and Gould City.

    The Agency has stated that the cannabis edibles are being recalled because the producer could not provide evidence the product is homogeneous.

    Additionally, the product  – called ‘Sweet Cheeks’ – allegedly exceeds the maximum dose of 10mg of THC per serving.

    The agency has warned that any consumers who have bought one of these products to return them to the sales location it was purchased from for “proper disposal: and that anyone who has experienced adverse reactions after using these products should report their symptoms and product use to their healthcare providers.

    The Agency stated: “Consumers are encouraged to also report any adverse reactions to marijuana product to the CRA by completing this Adverse Reaction Form and submitting it according to the instructions included or by phone at 517-284-8599.

    “A licensee that becomes aware of any adverse reactions to a marijuana product must notify the CRA and enter the information into METRC within one business day.”

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free